Novo Nordisk A/S Class B (NNO2)

Vienna
Currency in EUR
83.70
-0.55(-0.65%)
Closed

NNO2 Income Statement

Advanced Income Statement
Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa126,946140,800176,954232,261290,403
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+4.04%+10.91%+25.68%+31.26%+25.03%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa20,93223,65828,42435,31943,560
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa106,014117,142148,530196,942246,843
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+4%+10.5%+26.79%+32.59%+25.34%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa83.51%83.2%83.94%84.79%85%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa51,88857,92572,91292,244106,964
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+4.93%+11.63%+25.87%+26.51%+15.96%
aa.aaaa.aaaa.aaaa.aaaa.aa15,46217,19923,26331,07540,072
aa.aaaa.aaaa.aaaa.aaaa.aa36,88641,05850,68361,59467,368
aa.aaaa.aaaa.aaaa.aaaa.aa-460-332-1,034-425-476
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa54,12659,21775,618104,698139,879
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+3.13%+9.41%+27.7%+38.46%+33.6%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa42.64%42.06%42.73%45.08%48.17%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-53-58-139527198
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+65.81%-9.43%-139.66%+479.14%-62.43%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-390-289-378-542-1,640
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa3372312391,0691,838
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-748198-5,0211,536-1,329
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa53,32559,35770,458106,761138,748
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa--573-809-2,124-10,562
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa53,13059,08069,062104,674127,191
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+9.43%+11.2%+16.9%+51.57%+21.51%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa41.85%41.96%39.03%45.07%43.8%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa10,99211,32313,53720,99126,203
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa42,13847,75755,52583,683100,988
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa42,13847,75755,52583,683100,988
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+8.18%+13.33%+16.27%+50.71%+20.68%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa33.19%33.92%31.38%36.03%34.78%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa42,13847,75755,52583,683100,988
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa9.0310.412.2618.6722.67
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+10.05%+15.18%+17.87%+52.32%+21.46%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa9.0110.3712.2218.6222.63
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+9.95%+15.16%+17.84%+52.37%+21.54%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa4,667.84,593.24,530.64,482.84,453.9
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa4,6804,606.24,544.64,494.84,463
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa4.555.26.29.411.4
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+8.98%+14.29%+19.23%+51.61%+21.28%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa58,56563,77081,119110,523146,669
EBITDA Growth
aa.aa